Cargando…

Dupilumab as a novel therapy to treat adrenergic urticaria

Detalles Bibliográficos
Autores principales:	Goodman, Brian, Jariwala, Sunit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327453/ https://www.ncbi.nlm.nih.gov/pubmed/32621993 http://dx.doi.org/10.1016/j.anai.2020.06.034

Ejemplares similares

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

Severe pemphigoid nodularis successfully treated with dupilumab
por: Jendoubi, Fatma, et al.
Publicado: (2022)

A Case of Adrenergic Urticaria Associated with Vitiligo
por: Lang, Caroline, et al.
Publicado: (2016)

Long-term follow-up of patients treated with dupilumab for chronic spontaneous urticaria: A case report
por: Abadeh, Armin, et al.
Publicado: (2022)

Reactive perforating collagenosis successfully treated with dupilumab
por: Gil‐Lianes, Javier, et al.
Publicado: (2022)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
por: Patchinsky, Alexandra, et al.
Publicado: (2023)

Dupilumab-associated Facial Erythema Successfully Treated With Oral Ivermectin
por: Liane, Javier Gil, et al.
Publicado: (2022)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective?
por: Barei, Francesca, et al.
Publicado: (2022)

Ophiasis treated with dupilumab
por: Abercrombie, McKenna, et al.
Publicado: (2021)

Yellow urticaria in a patient on prophylactic antiretroviral therapy
por: Mendes, Luciana, et al.
Publicado: (2018)

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
por: Zhu, Changhua, et al.
Publicado: (2022)

Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series
por: Seok, Seung Hui, et al.
Publicado: (2020)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Dupilumab: One therapy to treat multiple atopic diseases
por: Bawany, Fatima, et al.
Publicado: (2020)

Cholinergic Urticaria, an Effective and Safe “Off Label” Use of Dupilumab: A Case Report with Literature Review
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
por: Thomsen, Simon Francis, et al.
Publicado: (2015)

Pemphigoid gestationis treated with dupilumab
por: Chen, Rita E., et al.
Publicado: (2023)

Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report
por: Gelato, Federica, et al.
Publicado: (2022)

Yellow Urticaria
por: Kränke, Teresa, et al.
Publicado: (2022)

Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
por: Tanabe, Naoya, et al.
Publicado: (2021)

Association of β2-Adrenergic Receptor Polymorphism with the Phenotype of Aspirin-Intolerant Acute Urticaria
por: Kim, Hyoun-Ah, et al.
Publicado: (2007)

Urticaria Treated by Adrenalin
Publicado: (1913)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

Contact Urticaria to Glycolic Acid Peel
por: Vishal, B, et al.
Publicado: (2012)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

Urticaria multiforme: a case report in an infant()()
por: Luce, Maria Claudia Alves, et al.
Publicado: (2019)

Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
por: Pop, Samantha R., et al.
Publicado: (2022)

Cicatricial ectropion in a patient treated with dupilumab
por: Barnes, Alexander C., et al.
Publicado: (2017)

Painless thyroiditis in a dupilumab-treated patient
por: Narantsatsral, Daramjav, et al.
Publicado: (2020)

A Case of Papuloerythroderma Successfully Treated with Dupilumab
por: Mizuno, Ayaka, et al.
Publicado: (2022)

Vitiligo during dupilumab therapy
por: Picone, Vincenzo, et al.
Publicado: (2023)

COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2020)

Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis
por: Bostan, Ecem, et al.
Publicado: (2021)

Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
por: Wiggins, Simmi, et al.
Publicado: (2023)

Coexistence of granuloma annulare and chronic spontaneous urticaria
por: Topal, Ilteris Oguz, et al.
Publicado: (2016)

Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study
por: Bakker, Daphne S., et al.
Publicado: (2021)

Dupilumab: a novel treatment for asthma
por: Vatrella, Alessandro, et al.
Publicado: (2014)

Chronic urticaria and use of statins
por: Khan, Sujoy
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_11gu2tmrfv7lm54d08e507vnji